FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113762.1.4.1213.113.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1213.113/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.113
Version20231212
Statusactive
Date2023-12-12T11:17:50-05:00
NameAntiplateletIngredientsAndRiskOfGIBleeding
TitleAntiplatelet Ingredients and Risk of GI Bleeding
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for oral antiplatelet medications.),(Data Element Scope: This value set use RxCui codes ingredient level to identify antiplatelet medications),(Inclusion Criteria: Includes RxNorm codes that describe ingredients that are antiplatelets),(Exclusion Criteria: Excludes concepts that describe other ingredients that are not the antiplatelet of interest)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1213.113",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2024-12-06T14:52:24.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Meaningful Drug Interaction Alerts Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-12-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2023-12-12"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.113",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1213.113"
    }
  ],
  "version": "20231212",
  "name": "AntiplateletIngredientsAndRiskOfGIBleeding",
  "title": "Antiplatelet Ingredients and Risk of GI Bleeding",
  "status": "active",
  "date": "2023-12-12T11:17:50-05:00",
  "publisher": "Meaningful Drug Interaction Alerts Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for oral antiplatelet medications.),(Data Element Scope: This value set use RxCui codes ingredient level to identify antiplatelet medications),(Inclusion Criteria: Includes RxNorm codes that describe ingredients that are antiplatelets),(Exclusion Criteria: Excludes concepts that describe other ingredients that are not the antiplatelet of interest)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "10594",
            "display": "ticlopidine"
          },
          {
            "code": "1116632",
            "display": "ticagrelor"
          },
          {
            "code": "1656052",
            "display": "cangrelor"
          },
          {
            "code": "21107",
            "display": "cilostazol"
          },
          {
            "code": "32968",
            "display": "clopidogrel"
          },
          {
            "code": "3521",
            "display": "dipyridamole"
          },
          {
            "code": "613391",
            "display": "prasugrel"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:16ebc238-ddb6-4fdc-a623-7135e7242269",
    "timestamp": "2025-05-23T19:20:29-04:00",
    "total": 7,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "10594",
        "display": "ticlopidine"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1116632",
        "display": "ticagrelor"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1656052",
        "display": "cangrelor"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "21107",
        "display": "cilostazol"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "32968",
        "display": "clopidogrel"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "3521",
        "display": "dipyridamole"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "613391",
        "display": "prasugrel"
      }
    ]
  }
}